Home > Insider Trading > Filing (0001104659-24-036710)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1860543	Cadre Holdings Inc.	CDRE	()	1231

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
935577	B Warren Kanders	C/O Kanders &Amp; Company, Inc. 250 Royal Palm Way, Suite 201 Palm Beach FL 33480	Ceo And Chairman	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share ("Common Stock")	Disposition	2024-03-19	1,438,127	$35.00	12,184,918	No	4	S	Indirect	By Kanders SAF, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Kanders SAF, LLC

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Acquisiton	2024-03-18	33,540	$0.00	33,540	$0.00
Common Stock	Stock Option (right to purchase)	Acquisiton	2024-03-18	105,682	$0.00	105,682	$34.66

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
33,540			No	4	A	Direct
105,682		2034-03-18	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	23,992	Direct
Common Stock	1,305,650	Indirect	By Warren B. Kanders Roth IRA
Common Stock	23,450	Indirect	By Allison Kanders Roth IRA

Footnotes

The Reporting Person is the sole manager and member of Kanders SAF, LLC.
Allison Kanders is the Reporting Person's spouse.
Comprised of a restricted stock units award granted under the Cadre Holdings, Inc. (the "Issuer") 2021 Stock Incentive Plan (the "Plan") consisting of 33,540 shares of the Issuer's Common Stock. 11,180 shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 18, 2025, March 18, 2026 and March 13, 2027, respectively.
The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 35,228 shares of the Issuer's Common Stock will vest and become exercisable on March 18, 2025 and options to purchase 35,227 shares of the Issuer's Common Stock will vest and become exercisable on each of March 18, 2026 and March 18, 2027, respectively.
The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities.